MedTrace Logo

Simulated In-House Usability Study of Eclipse Continuous Positive Airway Pressure (CPAP) Device

NCT05570747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-11-10

Study results available
· View outcomes & findings →

Summary

The study is designed to assess the usability of a novel CPAP human interface compared to a traditional nasal mask. Human subjects will interact with two different CPAP interfaces including a traditional CPAP mask and the 2nd generation DreamPort-Eclipse. Subjects will be requested to put on each of the different CPAP interface options a total of three times for a total of 6 trials. The order of device will be randomized.

Conditions

Interventions

OTHER

Usability

Patients will be observed and asked a serious of questions while they put the mask on and after they remove it.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Bleep, LLC

    lead INDUSTRY

Principal Investigators

  • Stuart Heatherington · Bleep, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2022-11-11
Completion
2022-11-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570747 on ClinicalTrials.gov